David Mitchell, a prominent advocate for lower prescription drug prices, died on January 2 at his home in Annapolis, Maryland. He was 75. Mitchell's family confirmed the cause of death was multiple myeloma, a blood cancer he battled for 15 years.
After a 2010 cancer diagnosis, Mitchell shifted from retirement plans to activism. By 2016, his medication costs reached $300,000 annually. This personal experience fueled his fight against high drug prices. He founded Patients For Affordable Drugs Now, becoming a leading voice in the movement.
Mitchell's advocacy challenged pharmaceutical industry practices. His work highlighted the financial burdens faced by many patients. The organization he founded will likely continue his mission.
Prior to his activism, Mitchell was a founding partner at GMMB, a Washington-based communications firm. He leveraged his PR expertise to raise awareness about drug pricing issues. His efforts aimed to make medications more accessible.
The future of drug pricing legislation remains uncertain. Mitchell's legacy will continue to influence the debate. His organization is expected to push for policy changes.
Discussion
Join the conversation
Be the first to comment